Online citations, reference lists, and bibliographies.
← Back to Search

Recent Advances In The Treatment Of Psoriasis.

E. Farber, E. Abel, A. Charuworn
Published 1983 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Because psoriasis is a disease of unknown etiology, all treatments are based on empirical experience and diverse scientific theories. Although there is no present cure for psoriasis, many forms of therapy are effective in control of the disorder. These range from topical medications such as tar, anthralin, corticosteroids; phototherapy and photochemotherapy; systemic medication, including cytotoxic agents; and vitamin A analogues or retinoids. This report focuses on modifications of existing therapies based on advances in basic science knowledge and technology, combination therapies, as well as new therapeutic agents and new approaches to the treatment of psoriasis.
This paper references
10.1111/j.1365-2133.1966.tb12221.x
DITHRANOL PASTE FOR PSORIASIS.
R. Seville (1966)
10.1111/j.1365-2230.1981.tb02275.x
0.5% Dethranol cream in the treatment of psoriasis
H. Baker (1981)
10.1111/j.1365-2133.1967.tb11537.x
THE TREATMENT OF PSORIASIS WITH TRIACETOXYANTHRACENE
F. Hellier (1967)
Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Mustakallio Kk (1980)
10.1001/ARCHDERM.1976.01630310005001
Photochemotherapy for psoriasis with orally administered methoxsalen.
K. Wolff (1976)
10.1111/j.1365-2133.1980.tb07656.x
The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis
E. Saihan (1980)
10.1001/ARCHDERM.1981.01650100013019
Nature of skin fragility in patients receiving retinoids for systemic effect.
M. Williams (1981)
10.1001/ARCHDERM.1976.01630330019003
Ultraviolet light and tar in the Goeckerman treatment of psoriasis.
A. Marsico (1976)
10.1111/j.1365-2133.1981.tb00755.x
Low‐dose PUVA maintenance in psoriasis following Ingram therapy
P.C.M. Kerkhof (1981)
10.1001/ARCHDERM.1975.01630160057004
Tar photoxicity and phototherapy for psoriasis.
L. Tanenbaum (1975)
10.1159/000250880
Tissue changes in psoriatic plaques after oral administration of retinoid.
C. Orfanos (1978)
10.1016/S0190-9622(82)70058-1
International studies of the efficacy of etretinate in the treatment of psoriasis.
C. Ehmann (1982)
10.1016/S0140-6736(81)91361-1
ACUTE MYELOMONOCYTIC LEUKAEMIA AFTER RAZOXANE THERAPY
R. Joshi (1981)
10.1159/000254424
Histochemical Changes in Treated and Untreated Psoriasis
D. Suurmond (1966)
10.1111/j.1365-2133.1981.tb00885.x
The atrophogenic effect of crude coal tar on human epidermis
R. Lavker (1981)
10.1016/S0140-6736(80)91231-3
SKIN CARCINOMA IN PATIENTS WITH PSORIASIS TREATED WITH TOPICAL TAR AND ARTIFICIAL ULTRAVIOLET RADIATION
R. Stern (1980)
10.1016/S0190-9622(82)70005-2
Combined methotrexate-PUVA therapy in the treatment of psoriasis.
W. Morison (1982)
10.1016/S0190-9622(82)70056-8
General clinical toxicology of oral retinoids.
D. Windhorst (1982)
10.1001/ARCHDERM.1978.01640130007001
Crude coal tar plus near ultraviolet light suppresses DNA synthesis in epidermis.
R. Stoughton (1978)
Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics.
A. Nyfors (1978)
10.1111/1523-1747.EP12541710
Potential ocular complications from PUVA therapy and their prevention.
S. Lerman (1980)
10.1056/NEJM197412052912301
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.
J. Parrish (1974)
10.1111/j.1365-2133.1982.tb00922.x
Short‐duration (‘minutes’) therapy with dithranol for psoriasis: a new out‐patient regimen
U. Runne (1982)
10.1159/000252139
The interaction of anthralin, salicylic acid and zinc oxide in pastes.
H. Hulsebosch (1972)
10.1016/S0161-6420(79)35468-9
Blepharoconjunctivitis: a side effect of 13-cis-retinoic acid therapy for dermatologic diseases.
H. Blackman (1979)
10.1111/1523-1747.EP12581626
Components of the Goeckerman regimen.
M. J. Le Vine (1979)
10.1111/j.1365-2133.1978.tb06538.x
Updating the Goeckerman regimen for psoriasis
J. Petrozzi (1978)
10.1159/000254496
Histologic changes in treated and untreated psoriatic lesions.
D. Suurmond (1965)
10.1001/ARCHDERM.1970.04000040003003
Hospital treatment of psoriasis. A modified anthralin program.
E. Farber (1970)
10.1111/j.1600-0560.1979.tb01170.x
Low Strength Anthralin in Psoriasis
L. Montes (1979)
10.1111/j.1600-0560.1977.tb00912.x
A Topical Treatment Program for Psoriasis with Low Anthralin Concentrations
I. Brody (1977)
10.1111/j.1365-2133.1980.tb08145.x
Razoxane (ICRF 159) in the treatment of psoriasis
D. Atherton (1980)
10.1007/978-3-642-68023-6_56
Retinoid and Skin Cancer Prevention
L. Schnitzler (1981)
10.1016/S0190-9622(82)70054-4
Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids.
J. Kamm (1982)
10.1111/j.1365-2133.1980.tb05693.x
Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double‐blind trial
H. Rhee (1980)
10.1007/978-3-642-68023-6_36
Comparative Analysis of Two Retinoids in the Treatment of Disorders of Keratinization
G. Peck (1981)
10.1111/j.1365-2133.1961.tb14996.x
THE TREATMENT TIME IN PSORIASIS *
A. MacLennan (1961)
10.1056/NEJM197904123001501
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
R. Stern (1979)
10.1111/j.1365-2133.1980.tb01661.x
Oral retinoids‐present status
C. Orfanos (1980)
10.1007/978-3-642-68023-6_26
Aromatic Retinoid (Ro 10-9359), RePUVA and PUVA in the Treatment of Psoriasis
J. Lauharanta (1981)
10.1016/S0190-9622(82)70053-2
Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
R. Brazzell (1982)
10.1016/S0190-9622(81)80241-1
Coal tar, ultraviolet light, and cancer
S. Muller (1981)
Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin).
J. Søndergaard (1976)
10.1001/ARCHDERM.1976.01630360047013
An appraisal of current systemic chemotherapy for psoriasis.
E. Farber (1976)
10.1021/JM00294A002
Structure and tumor-promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds.
A. Segal (1971)
10.1001/ARCHDERM.1979.04010070016013
Tar gel-phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation.
P. Frost (1979)
10.1111/j.1365-2133.1980.tb07657.x
Limited application period for dithranol in psoriasis
H. Schaefer (1980)
10.1136/bmj.2.4836.591
The Approach to Psoriasis*
J. Ingram (1953)
Psoriasis: treatment with a tar gel.
Cram Dl (1976)
10.1159/000254449
I. Communications – Mitteilungen. Experimentelle Untersuchungen über den Wirkungsmechanismus von Chrysarobin und Dithranol bei Psoriasis (Indizien für eine cytostatische Wirkung an der Epidermis)
A. Krebs (1965)
10.1016/S0140-6736(79)90820-1
COMPARISON OF PHOTOCHEMOTHERAPY AND DITHRANOL IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS
S. Rogers (1979)
10.1111/j.1365-2133.1976.tb15541.x
Systemic use of a new retinoid with and without local dithranol treatment in generalized psoriasis
C. Orfanos (1976)
10.1111/J.1365-2133.1978.TB01616.X
Psoriasis and stress. II
R. Seville (1978)
10.1016/S0190-9622(80)80398-7
Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy.
R. Hanno (1980)
10.1056/NEJM197902153000701
Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid.
G. Peck (1979)
10.1111/j.1365-2133.1981.tb00957.x
A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis
J. Lauharanta (1981)
10.1111/j.1365-2133.1977.tb15186.x
Psoriasis and stress *
R. Seville (1977)
10.1111/j.1365-2133.1975.tb06742.x
Simplified dithranol treatment for psoriasis *
R. Seville (1975)
10.1111/j.1365-2133.1977.tb05201.x
Photochemotherapy in the treatment of psoriasis
T. Lakshmipathi (1977)
10.1111/j.1365-2133.1978.tb01611.x
Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis
W. Morison (1978)
10.1001/ARCHDERM.1981.01650110065024
Molecular basis of dermatologic disease.
J. Parrish (1981)
10.1111/1523-1747.EP12520022
Action spectrum for phototherapy of psoriasis.
J. Parrish (1981)
10.1016/S0190-9622(81)70098-7
Advances in the use of anthralin.
R. Seville (1981)
10.1016/S0190-9622(82)70120-3
Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
E. Abel (1982)
10.1016/S0190-9622(82)70057-X
A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
S. Glazer (1982)
10.1111/1523-1747.EP12541294
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.
P. Fritsch (1978)
10.1111/1523-1747.EP12479366
Phototherapy and photochemotherapy of skin diseases.
J. Parrish (1981)



This paper is referenced by
10.1016/S0190-9622(89)70015-3
Stress and psoriasis: the importance of insight and empathy in prognosis.
R. Seville (1989)
10.1111/j.1346-8138.1988.tb01194.x
Comparison of Therapeutic Efficacy of Topical PUVA, Oral Etretinate, and Combined PUVA and Etretinate for the Treatment of Psoriasis and Development of PUVA Lentigines and Antinuclear Antibodies
A. Takashima (1988)
10.1007/978-3-662-00181-3_14
Erythematous and Erythematosquamous Skin Diseases
O. Braun-Falco (1991)
10.2165/00003495-198428040-00003
Psoriasis. A review of recent advances in treatment.
E. Farber (1984)
10.1159/000017934
Low-Dose Narrow-Band UVB Phototherapy Combined with Topical Therapy Is Effective in Psoriasis and Does Not Inhibit Systemic T-Cell Activation
M. D. de Rie (1998)
10.1007/BF00413248
Topical treatment of psoriasis with the topoisomerase inhibitors novobiocin and nalidixic acid: A pilot study
V. Bohr (2004)
10.1038/JID.1987.12
The effect of tar and ultraviolet on the skin.
J. Comaish (1987)
10.1046/J.1365-2753.2002.00372.X
What criteria do patients use when judging the effectiveness of psoriasis management?
S. Ersser (2002)
10.1046/j.1365-2133.1999.140S54018.x
Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis
Gollnick (1999)
10.1056/NEJM198511283132210
AIDS exacerbates psoriasis.
T. Johnson (1985)
10.1046/j.1365-4362.1999.00500.x
The role of salicylic acid in the treatment of psoriasis
M. Lebwohl (1999)
10.1111/j.1346-8138.1998.tb02357.x
Factors Influencing Psoriasis: An Analysis Based upon the Extent of Involvement and Clinical Type
B. S. Park (1998)
10.1016/S0190-9622(84)80157-7
Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
L. Pearson (1984)
10.1016/S0190-9622(84)70099-5
White paper on hospitalization for psoriasis care.
M. Bohm (1984)
10.1007/978-3-642-76107-2_33
Hauterkrankungen des äußeren Genitales
T. Berger (1992)
10.1111/j.1365-2710.2006.00747.x
The effect of various methods of psoriasis treatment on somatotrophin axis hormones in serum
A. Damasiewicz-Bodzek (2006)
10.1038/clpt.1987.209
Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans
D. Mays (1987)
10.1046/j.1365-4362.2000.00862.x
Improvement in psoriasis after intradermal administration of heat‐killed Mycobacterium vaccae
M. V. Balagon (2000)
Photo(chemo)therapeutic modulation of the skin immune system [ch 40]
A. RiedeM. (1997)
10.1001/ARCHDERM.1985.01660120031014
Short-contact therapy.
H. Schaefer (1985)
10.1016/S0733-8635(05)70191-1
Treatment of patients hospitalized for psoriasis.
S. Prodanovich (2000)
10.1016/S0161-6420(95)30835-4
Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease.
L. Lane (1995)
10.1016/S0065-7743(08)61168-9
Chapter 20 Dermatological Agents
M. C. Venuti (1987)
10.1046/j.1365-2230.2001.00804.x
Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC™): results of an open‐label trial
M. V. Balagon (2001)
10.1007/978-94-011-3620-4_10
Synthesys of Isoxazole and Isoxazoline Derivatives of Retinoids: Effects on Growth and Differentiation of Tumor Cells
D. Simoni (1991)
10.1007/978-3-642-74612-3_25
Seborrhoeic Dermatitis, Scalp Psoriasis and Hair
C. Orfanos (1990)
10.1016/S0190-9622(85)70087-4
Psoriasis treatment at the Dead Sea: a natural selective ultraviolet phototherapy.
D. J. Abels (1985)
10.1046/j.1365-2133.2003.05173.x
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo‐controlled randomized trial
E. D. de Jong (2003)
10.1016/B978-0-7236-0777-9.50012-3
Chapter six – Psoriasis, Relapsing Polychondritis and Inflammatory Bowel Disease
W. J. Dinning (1987)
10.1007/978-3-662-47039-8_13
Surfactants as Penetration Enhancers for Dermal and Transdermal Drug Delivery
T. Ghafourian (2015)
10.5124/JKMA.2006.49.2.150
Treatment of Psoriasis
J. I. Youn (2006)
10.1111/j.1346-8138.1998.tb02360.x
The Effectiveness of Modified Ingram Therapy Compared with Severity of Psoriasis
J. I. Youn (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar